Serum ferritin and ceruloplasmin as coronary risk factors
The DOI matches its Crossref record.
Abstract
Iron and copper catalyze lipid peroxidation in vitro, and recent epidemiological data suggest that these metal ions might also be involved in human coronary heart disease. We tested the hypothesis by investigating whether the storage proteins ferritin and ceruloplasmin were coronary risk factors. A nested case-control study was set up in middle-aged dyslipidaemic participants of the Helsinki Heart Study: a placebo-controlled coronary primary prevention trial with gemfibrozil. Of the 140 subjects with cardiac end-points (non-fatal myocardial infarction or cardiac death) 136 were matched with controls for geographical area and drug treatment (gemfibrozil-placebo). Frozen baseline serum samples were used in the analyses of ferritin and ceruloplasmin. Using logistic regression analyses no increment in coronary risk was detected with increasing ferritin levels (P = 0.8 for trend). Ceruloplasmin was higher 349 +/- 86 vs 317 +/- 77 mg.l-1 (P < 0.001) in cases than in controls and the risk in the highest tertile was two-fold (odds ratio 2.1; 95% CI 1.1-4.2) compared to the lowest (P < 0.005 for trend). The risk of high ceruloplasmin was influenced by lipoprotein cholesterol concentrations, with an odds ratio of 2.4 (95% CI 1.3-4.4) in subjects with high low density lipoprotein cholesterol and of 11.3 (95% CI 2.5-52.2) in subjects with low high density lipoprotein cholesterol. It was concluded that ferritin was not associated with coronary heart disease in dyslipidaemic, middle-aged men, while there was a continuous and graded increment in coronary risk with elevating ceruloplasmin level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Copper, oxidative stress, and human health
Uriu-Adams, J. Y., & Keen, C. L. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.015 · Cited by 975
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Khovidhunkit, Memon, R. A., Feingold, K. R., & Grunfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403
Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men
Tuomainen, T.-P., Punnonen, K., Nyyssönen, K., & Salonen, J. T. (1998) · Circulation · doi:10.1161/01.cir.97.15.1461 · Cited by 286
“27,36,37 Since our original study, the association of body iron and the risk of fatal CHD or AMI has been studied in at least nine other prospective epidemiological studies, of which only two have used serum ferritin as the measure of body iron and published a full report.(14,19)”
BackgroundIron, Atherosclerosis, and Ischemic Heart Disease
de Valk, B., & Marx, J. J. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.14.1542 · Cited by 250
Coronary Heart Disease and Iron Status: Meta-Analyses of Prospective Studies
Danesh, J., & Appleby, P. (1999) · Circulation · doi:10.1161/01.cir.99.7.852 · Cited by 226
“Approximate baseline mean (SD) 160 (100) mg/L 30 (10)% 65 (10) mmol/L 18 (6) mmol/L 15 (5) mg/d”
Metadata
- Authors
- MäNTTäRI, M., MANNINEN, V., HURRUNEN, J. K., PALOSUO, T., EHNHOLM, C., HEINONEN, O. P., & FRICK, M. H.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-12
- Volume
- 15
- Issue
- 12
- Pages
- 1599-1603
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2265791998
- Cited by
- 145
- References
- 0
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum ferritin and ceruloplasmin as coronary risk factors. https://app.cochat.ai/papers/10.1093/oxfordjournals.eurheartj.a060440
- The paper
- MäNTTäRI, M., MANNINEN, V., HURRUNEN, J. K., PALOSUO, T., EHNHOLM, C., HEINONEN, O. P., & FRICK, M. H. (1994). Serum ferritin and ceruloplasmin as coronary risk factors. European Heart Journal. https://doi.org/10.1093/oxfordjournals.eurheartj.a060440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.